Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $27.21M.
ENTERPRISE VALUE (EV)
$27.21M
ABVC BioPharma, Inc.
Market Cap
$24.42M
Enterprise Value (EV)
$27.21M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $24.42M | $27.21M |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.54M | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.05M | N/A |
| InspireMD, Inc. (NSPR)vs › | $25.47M | $12.29M |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.26M | $19.64M |
| Rein Therapeutics Inc. (RNTX)vs › | $23.04M | $14.50M |
| iTonic Holdings Ltd. (ITOC)vs › | $25.98M | $25.44M |
| Modular Medical, Inc. (MODD)vs › | $22.49M | $18.85M |
| LeonaBio, Inc. (LONA)vs › | $22.28M | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | $13.69M |
Market Cap
$24.42M
Total Debt
$3.47M
Cash
$681480.00
Enterprise Value
$27.21M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
